Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

被引：0
|
作者：
Luis Almeida
Amílcar Falcão
Manuel Vaz-da-Silva
Teresa Nunes
Ana-Teresa Santos
José-Francisco Rocha
Carla Neta
Tice Macedo
C. Fontes-Ribeiro
P. Soares-da-Silva
机构：
[1] BIAL,Department of Research & Development
[2] 4Health Limited,undefined
[3] CEB – Centre for Bioavailability Studies,undefined
[4] AIBILI,undefined
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
Nebicapone; Warfarin; Drug interaction; Pharmacokinetics; Coagulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Tegaserod does not significantly affect the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Ledford, P
    On, N
    Ligueros-Saylan, M
    Campestrini, J
    Osborne, S
    GASTROENTEROLOGY, 2000, 118 (04) : A1184 - A1184
  • [32] Muraglitazar does not alter the pharmacokinetics and pharmacodynamics of concomitantly administered warfarin in healthy subjects
    Swaminathan, A
    Frost, C
    Nepal, S
    Raymond, R
    Reitberg, D
    Reeves, R
    Mosqueda-Garcia, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P81 - P81
  • [33] Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects
    Renli Teng
    Patrick Mitchell
    Kathleen Butler
    European Journal of Clinical Pharmacology, 2013, 69 : 877 - 883
  • [34] Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects
    Saari, Teijo I.
    Laine, Kari
    Leino, Kari
    Valtonen, Mika
    Neuvonen, Pertti J.
    Olkkola, Klaus T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (01) : 116 - 120
  • [35] Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects
    Niemi, M
    Backman, JT
    Neuvonen, M
    Neuvonen, PJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 427 - 432
  • [36] Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects
    Gelal, A
    Balkan, D
    Ozzeybek, D
    Kaplan, YC
    Gurler, S
    Guven, H
    Benowitz, NL
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (11) : 785 - 790
  • [37] Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects
    Teng, Renli
    Mitchell, Patrick
    Butler, Kathleen
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 877 - 883
  • [38] Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects
    Ayse Gelal
    Dilara Balkan
    Deniz Ozzeybek
    Yusuf C. Kaplan
    Selma Gurler
    Hulya Guven
    Neal L. Benowitz
    European Journal of Clinical Pharmacology, 2005, 60 : 785 - 790
  • [39] Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
    He, Yan-Ling
    Sabo, Ron
    Riviere, Gilles-Jacques
    Sunkara, Gangadhar
    Leon, Selene
    Ligueros-Saylan, Monica
    Rosenberg, Mitchell
    Dole, William P.
    Howard, Dan
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 1131 - 1138
  • [40] Pharmacodynamics and pharmacokinetics during the transition from warfarin to rivaroxaban: a randomized study in healthy subjects
    Kubitza, Dagmar
    Becka, Michael
    Mueck, Wolfgang
    Kraetzschmar, Joeern
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (02) : 353 - 363
12345